2006, Number 2
<< Back Next >>
Rev Med UV 2006; 6 (2)
Sleep disorders
Venebra MA, Santiago GJ, García GF
Language: Spanish
References: 32
Page: 18-28
PDF size: 946.02 Kb.
ABSTRACT
Sleep is a biological phenomena present in all mammals, including humans. A 70-year-old person has slept for at least 20 years, being this a third part of his life. Therefore sleep is one of the best preserved and most fascinating conducts to study. Currently, more than 100 sleeping disorders have been described and it is estimated that two thirds of the Mexican populationfrom youngsters to adults - have, throughout their life, at least one sleeping disorder, being the most common one insomnia episodes. Most of the sleep disorders are obviated, firstly by the patients who, in general, are not aware of their existence and consider conducts such as snoring as “normal” sleep situations. Secondly, because the medical community does not have, most of the time, with the appropriate information and training to treat sleep pathologies; which translates in a lack of centres or clinics specialized in sleep disorders. In the present review the main sleeping disorders, causes that produce them, some treatment plans and, finally, the brain mechanisms involved in their appearance will be addressed.
REFERENCES
Purves D. Neuroscience. 2a ed. Sunderland (MA). Sinauer associates inc, 2001.
Vgontzas A.N, Kales A. Sleep and its disorders. Ann Rev Med 1999; 50: 387-400.
Wilson S, Nutt D. Insomnia: recommended practice management. Drug Rev 2003, 14: 45-56.
Weitzman E. Sleep and its disorders. Ann Rev Neurosc 1981; 4: 381-417.
Montagna P. Fatal familial insomnia: model disease in sleep physiopathology. Sleep Med Rev 2005; 9: 339-353.
Gambeti P. y col. Fatal familial insomnia and familial Crutzfeldt-Jacob disease: clinical, pathological and molecular features. Brain Pathol 1995; 5: 43-51.
Roth T, Roehrs TA. Etiologies and sequelae of excessive daytime sleepiness. Clin Ther 1996;18: 562-76.
National Sleep Foundation. Annual report, USA. 2004.
Alvarado R. Frecuencia del insomnio en México. Arch Neuroc Mex 1997; 2(2): 114-121.
Téllez L.A, Guerrero S.M, Gutiérrez T.F. Hábitos y trastornos del dormir en residentes del área metropolitana de Monterrey. Sal Ment 1995; 18 (1): 14-22.
Anuario estadístico de accidentes en carreteras federales 2002. Secretaría de Comunicaciones y Transportes. Instituto Mexicano del Transporte. Documento técnico No. Safandilla Querétaro, 2003.
Chauduri K, Appiah-Kubi L, Trenkwalder C. J Neurol Neurosurg Psychiatry 2001; 71: 143-146.
Montplaisir J y col. Retless legs syndrome and periodic limb movement disorder. En Kryger M, Roth T, Dement W, editor. Principles and practice of sleep medicine. Philadelphia: WB Saunders, 2000: 742-752.
Winkelman J.W. Considering the causes of RLS. Eur J Neurol 2006; 3: 8-14.
Zeman A y col. Narcolepsy and excessive daytime sleepiness. Clinic Rev 2004; 329: 724-727.
De Lecea L y col. The hypocretins: hypothalamicspecific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA 1998; 95: 322-327.
Sakurai T y col. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein–coupled receptors that regulate feeding behavior. Cell 1998; 92: 573-585.
Ebrahim I.O y col. The hypocretin/orexin system. J R Soc Med 2002; 95: 227-230.
Peralta-Adrados M.R. Neurobiologia de la narcolepsia. Neurol 2002; 17: 307-309.
Guilleminault Ch, Anagnos A. Narcolepsy. En Kryger M, Roth T, Dement W, editor. Principles and practice of sleep medicine. Philadelphia: WB Saunders, 2000: 676-686.
Nishino S, Okura M, Mignot E. Narcolepsy: genetic predisposition and neuropharmacological mechanisms. Sleep Med Rev 2000; 4: 57-99.
Kodotani H, Faraco J, Mignot E. Genetic studies in the sleep disorder narcolepsy. Genome Res 2006; 8: 427-434.
De Lecea L, Sutcliffe G. Hypocretins and sleep. FEBS J 2005; 272:5675-5688.
Lin L y col. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999; 98: 365-376.
Chemelli R y col. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999; 98: 437-451.
Hara J. y col. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia and obesity. Neuron 2001; 30: 345-354.
Peyron C y col. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000; 6: 991-997.
Thannickal T.C y col. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000; 27: 469-474.
Guilleminault Ch y col. Adult chronic sleepwalking and its treatment based on polysomnography. Brain 2005; 128: 1062-1069.
Remulla A, Guilleminault Ch. Sonambulism (sleep walking). Expert opinion pharmacother 2004; 5: 2069-2074.
Dauvilliers Y, Maret S, Tafti M. Genetics of normal and pathological sleep in humans. Sleep Med Rev 2005; 9: 91-100.
Full text